Physician profile
Maurice Beer
NPI 1619049558
$2,248.29
in general payments reported to CMS, 2019-2025
9 companies · $34.91 in 2025
The $34.91 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $264 · 2021: $316 · 2022: $465 · 2023: $419 · 2024: $203 · 2025: $34.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,406.15 | 2019-2025 | Xifaxan, Trulance |
| Allergan, INC. | $244.80 | 2020 | |
| Janssen Biotech, INC. | $198.68 | 2019 | |
| Lilly USA, LLC | $158.34 | 2023-2024 | Mounjaro |
| Abbvie INC. | $93.64 | 2019 | |
| Ibsa Pharma INC. | $72.06 | 2019 | |
| Merck Sharp & Dohme LLC | $43.74 | 2022-2023 | Dificid |
| Astrazeneca Pharmaceuticals LP | $17.99 | 2019 | |
| Snap Diagnostics LLC | $12.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Beer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.